1. Home
  2. IRWD vs CCRD Comparison

IRWD vs CCRD Comparison

Compare IRWD & CCRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • CCRD
  • Stock Information
  • Founded
  • IRWD 1998
  • CCRD 1973
  • Country
  • IRWD United States
  • CCRD United States
  • Employees
  • IRWD N/A
  • CCRD N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • CCRD
  • Sector
  • IRWD Health Care
  • CCRD
  • Exchange
  • IRWD Nasdaq
  • CCRD Nasdaq
  • Market Cap
  • IRWD 150.9M
  • CCRD 157.9M
  • IPO Year
  • IRWD 2010
  • CCRD N/A
  • Fundamental
  • Price
  • IRWD $0.71
  • CCRD $20.55
  • Analyst Decision
  • IRWD Buy
  • CCRD Hold
  • Analyst Count
  • IRWD 5
  • CCRD 1
  • Target Price
  • IRWD $4.94
  • CCRD $21.00
  • AVG Volume (30 Days)
  • IRWD 4.0M
  • CCRD 16.4K
  • Earning Date
  • IRWD 05-07-2025
  • CCRD 05-08-2025
  • Dividend Yield
  • IRWD N/A
  • CCRD N/A
  • EPS Growth
  • IRWD N/A
  • CCRD 187.14
  • EPS
  • IRWD N/A
  • CCRD 0.86
  • Revenue
  • IRWD $317,676,000.00
  • CCRD $61,011,000.00
  • Revenue This Year
  • IRWD N/A
  • CCRD $9.82
  • Revenue Next Year
  • IRWD N/A
  • CCRD N/A
  • P/E Ratio
  • IRWD N/A
  • CCRD $23.22
  • Revenue Growth
  • IRWD N/A
  • CCRD 12.31
  • 52 Week Low
  • IRWD $0.59
  • CCRD $11.57
  • 52 Week High
  • IRWD $8.23
  • CCRD $24.97
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 30.30
  • CCRD 57.31
  • Support Level
  • IRWD $0.88
  • CCRD $16.84
  • Resistance Level
  • IRWD $0.98
  • CCRD $20.30
  • Average True Range (ATR)
  • IRWD 0.10
  • CCRD 1.19
  • MACD
  • IRWD 0.01
  • CCRD 0.08
  • Stochastic Oscillator
  • IRWD 14.47
  • CCRD 72.50

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About CCRD CoreCard Corporation

CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.

Share on Social Networks: